206 related articles for article (PubMed ID: 11981294)
1. Abuse and toxicity of methylphenidate.
Klein-Schwartz W
Curr Opin Pediatr; 2002 Apr; 14(2):219-23. PubMed ID: 11981294
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate: abuse and addiction.
Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
[No Abstract] [Full Text] [Related]
3. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
Leonard BE; McCartan D; White J; King DJ
Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
[No Abstract] [Full Text] [Related]
4. Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination.
Coskun M; Zoroglu S
J Clin Psychopharmacol; 2008 Dec; 28(6):723-5. PubMed ID: 19011457
[No Abstract] [Full Text] [Related]
5. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
Aanonsen NO
Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
[TBL] [Abstract][Full Text] [Related]
6. Excessive masturbation and hypersexual behavior associated with methylphenidate.
Bilgiç A; Gürkan K; Türkoğlu S
J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):789-90. PubMed ID: 17581441
[No Abstract] [Full Text] [Related]
7. [Methylphenidate misuse].
Bruggisser M; Bodmer M; Liechti ME
Praxis (Bern 1994); 2012 Feb; 101(5):299-305. PubMed ID: 22377977
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.
Williams RJ; Goodale LA; Shay-Fiddler MA; Gloster SP; Chang SY
Am J Addict; 2004; 13(4):381-9. PubMed ID: 15370936
[TBL] [Abstract][Full Text] [Related]
9. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
McGough JJ; McBurnett K; Bukstein O; Wilens TE; Greenhill L; Lerner M; Stein M
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):351-6. PubMed ID: 16768642
[TBL] [Abstract][Full Text] [Related]
10. [Hallucinations caused by the introduction of methylphenidate at low doses].
Aguilera-Albesa S; Yoldi-Petri ME; Molins-Castiella T; Durá-Travé T
Rev Neurol; 2010 Aug; 51(4):254-5. PubMed ID: 20648469
[No Abstract] [Full Text] [Related]
11. Brief psychosis induced by methylphenidate in a child with attention deficit disorder: a case report and literature review.
Martínez-Aguayo JC; Arancibia M; Meza-Concha N; Bustamante C; Pérez-Bracchiglione J; Madrid E
Medwave; 2017 Jun; 17(5):e6980. PubMed ID: 28665917
[TBL] [Abstract][Full Text] [Related]
12. Depressive symptoms as a side effect of the sustained release form of methylphenidate in a 7-year-old boy with attention-deficit hyperactivity disorder.
Lakić A
Vojnosanit Pregl; 2012 Feb; 69(2):201-4. PubMed ID: 22500377
[TBL] [Abstract][Full Text] [Related]
13. [Drug dependence and methylphenidate].
Sora I; Ikari M; Ikeda K
Seishin Shinkeigaku Zasshi; 2008; 110(10):941-5. PubMed ID: 19278070
[No Abstract] [Full Text] [Related]
14. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
Kollins SH
J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
[TBL] [Abstract][Full Text] [Related]
15. Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.
Spiller HA; Hays HL; Aleguas A
CNS Drugs; 2013 Jul; 27(7):531-43. PubMed ID: 23757186
[TBL] [Abstract][Full Text] [Related]
16. Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study.
Bron TI; Bijlenga D; Kasander MV; Spuijbroek AT; Beekman AT; Kooij JJ
Eur Neuropsychopharmacol; 2013 Jun; 23(6):542-54. PubMed ID: 22809706
[TBL] [Abstract][Full Text] [Related]
17. [Methylphenidate induced ST elevation acute myocardial infarction].
Ruwald MH; Ruwald AC; Tønder N
Ugeskr Laeger; 2012 Mar; 174(10):647-8. PubMed ID: 22395014
[TBL] [Abstract][Full Text] [Related]
18. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
[TBL] [Abstract][Full Text] [Related]
19. Pediatric ADHD Medication Exposures Reported to US Poison Control Centers.
King SA; Casavant MJ; Spiller HA; Hodges NL; Chounthirath T; Smith GA
Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29784754
[TBL] [Abstract][Full Text] [Related]
20. Safety issues in the use of methylphenidate. An American perspective.
Rappley MD
Drug Saf; 1997 Sep; 17(3):143-8. PubMed ID: 9306050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
